LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New leukemia pill goes Head-to-Head with standard treatment in major trial
Disease control Recruiting nowThis study aims to compare the effectiveness and safety of a new oral drug called pirtobrutinib against the standard drug ibrutinib for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It will enroll about 660 participants, some who have had pri…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New weapon tested against stubborn blood cancers
Disease control Recruiting nowThis is the first study in people testing a new drug called MGD024 for several types of blood cancers that have come back or stopped responding to standard treatments. The main goal is to find a safe dose and understand how the drug works in the body. Researchers will also look f…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Triple-Punch cell therapy aims to outsmart tough childhood leukemia
Disease control Recruiting nowThis early-phase study is testing a new, experimental cell therapy called TRICAR-ALL for children and young adults (ages 1-25) whose B-cell acute lymphoblastic leukemia (ALL) has come back or hasn't responded to standard treatments. Doctors take a patient's own immune cells (T ce…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Feb 25, 2026 15:07 UTC